Auxilium names Tursi chief medical officer

Tuesday, August 16, 2011 10:07 AM

Auxilium Pharmaceuticals has promoted Dr. James P. Tursi to chief medical officer. Tursi will report to Armando Anido, chief executive officer and president of Auxilium, and sit on the Auxilium Executive Committee in this role.

Tursi joined Auxilium in March of 2009 and has been responsible for the oversight of clinical development, clinical operations, biometrics and medical writing. He led a team of 30 individuals involved in clinical activities across several indications. Prior to joining Auxilium, Turis served as medical director at Procter and Gamble Pharmaceuticals.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs